Feed ZTS
ZT

Zoetis ZTS · NYSE

$79.71 +0.42% (+$0.33)

Market cap
$32.8B
Enterprise value
$40.6B
P/E
12.5x
Forward P/E
11.3x
PEG
1.6x
P/S
3.4x
P/FCF
13.9x
EV/EBITDA
10.5x
ROIC
21.6%
Bruto marža
70.9%
Neto marža
27.5%
Dividend yield
2.63%
Payout ratio
33.0%
Neto dolg/EBITDA
2.0x
Beta
0.74
Free float
99.8%

O podjetju

Zoetis Inc. (ZTS) is a global pharmaceutical company focused on animal health, headquartered in the USA. The company specializes in the development, manufacturing, and sale of medications and vaccines for animals. Zoetis provides a wide range of products for animal treatment and disease prevention in both domestic pets and livestock. Their portfolio includes medications for animals such as dogs, cats, cattle, pigs, poultry, and others. With its research, innovations, and global presence, Zoetis has gained a leading position in the field of animal health. The company focuses on improving the quality of life for animals and supports animal health worldwide. Zoetis Inc. (ZTS) shares can be an attractive investment opportunity for investors monitoring the animal health sector and valuing stability and long-term growth in this industry.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Kristin C. Peck

Employees

14,500

Headquarters

Parsippany

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.